<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11785460</article-id><article-id pub-id-type="doi">10.7759/cureus.76721</article-id><article-categories><subj-group subj-group-type="heading"><subject>Gastroenterology</subject></subj-group><subj-group><subject>Pathology</subject></subj-group><subj-group><subject>Internal Medicine</subject></subj-group></article-categories><title-group><article-title>When Ascites Hides More: A Diagnostic Dilemma in an Unusual Presentation</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Gupta</surname><given-names>Abhinav</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Varun</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Goyal</surname><given-names>Manjeet K</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Khubber</surname><given-names>Manisha</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, IND </aff><aff id="aff-2">
<label>2</label>
Gastroenterology and Hepatology, Dayanand Medical College and Hospital, Ludhiana, IND </aff><author-notes><corresp id="cor1">
Abhinav Gupta <email>abhreebhu@yahoo.com</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>1</day><month>1</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>1</month><year>2025</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>e76721</elocation-id><history><date date-type="accepted"><day>31</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025, Gupta et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Gupta et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/327349-when-ascites-hides-more-a-diagnostic-dilemma-in-an-unusual-presentation">This article is available from https://www.cureus.com/articles/327349-when-ascites-hides-more-a-diagnostic-dilemma-in-an-unusual-presentation</self-uri><abstract><p>Eosinophilic ascites, a rare manifestation of eosinophilic gastroenteritis, is characterized by eosinophilic infiltration in the gastrointestinal tract and ascitic fluid. In this case, a 60-year-old male presented with abdominal pain and vomiting, with diagnostic challenges due to non-specific symptoms. The diagnosis was made based on history and eosinophil-rich ascites. Treatment with corticosteroids resulted in symptom improvement. This case emphasizes the importance of early recognition and prompt treatment to avoid unnecessary surgical intervention in patients with unexplained ascites.</p></abstract><kwd-group kwd-group-type="author"><kwd>diagnostic challenges</kwd><kwd>eosinophil counts</kwd><kwd>eosinophilic ascites</kwd><kwd>eosinophilic gastro-intestinal disorders</kwd><kwd>eosinophilic gastrointestinal disorders</kwd><kwd>infectious and parasitic diseases</kwd><kwd>steroid use</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Eosinophilic gastrointestinal diseases (EGIDs) are chronic, immune-mediated disorders of the gastrointestinal tract that are characterized by abnormal eosinophil-predominant tissue inflammation. These diseases can occur at any age but are usually present in the third to fifth decades of life [<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF2" ref-type="bibr">2</xref>]. The pathogenesis remains unclear, although multiple studies postulate possible allergic components as 50-70% of patients have concomitant atopic diseases [<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF3" ref-type="bibr">3</xref>,<xref rid="REF4" ref-type="bibr">4</xref>]. The clinical presentation varies based on the location and extent of bowel involvement.</p><p>EGIDs are classified into mucosal, muscular, and serosal types [<xref rid="REF5" ref-type="bibr">5</xref>,<xref rid="REF6" ref-type="bibr">6</xref>]. Mucosal disease (70%), the most common form, causes non-specific symptoms, while muscular involvement (20%) leads to motility issues and obstruction [<xref rid="REF7" ref-type="bibr">7</xref>-<xref rid="REF9" ref-type="bibr">9</xref>]. Serosal disease (10%), the rarest, presents with eosinophilic ascites in isolation or along with symptoms of mucosal and/or muscular disease [<xref rid="REF1" ref-type="bibr">1</xref>]. This case report presents a rare occurrence of eosinophilic ascites in a patient presenting with abdominal pain, highlighting diagnostic challenges, therapeutic interventions, and clinical outcomes.</p></sec><sec sec-type="cases"><title>Case presentation</title><p>A 60-year-old male presented with abdominal pain and vomiting for one week. This was his first presentation and his first-ever hospitalization. There was no personal or family history of asthma, allergic rhinitis, atopic dermatitis, seasonal allergies, or any other allergic disorder. Clinical examination was unremarkable. His routine laboratory tests revealed normal hemoglobin (139 g/L), WBC count (11.8 &#x000d7; 10<sup>9</sup>/L) (Table&#x000a0;<xref rid="TAB1" ref-type="table">1</xref>), and normal platelet count (265 &#x000d7; 10<sup>9</sup>/L). The comprehensive metabolic profile was within normal limits. Urinalysis, ECG, and chest X-ray examination were also normal. Ultrasonography of the abdomen was suggestive of minimal free fluid in the abdomen, which was not amenable to aspiration. He was treated empirically with anti-spasmodic and anti-emetics. However, his symptoms persisted, and therefore, a contrast-enhanced computed tomography of the abdomen and pelvis was done, which revealed circumferential wall thickening involving the stomach and the first part of the duodenum (Figure&#x000a0;<xref rid="FIG1" ref-type="fig">1</xref>). He underwent an upper gastrointestinal endoscopy, which was normal, and segmental biopsies were taken for histopathological analysis. IgG4 levels and tumor markers were normal. A diagnostic laparoscopy was planned. The subsequent day hemogram revealed a total leukocyte count (TLC) of 11.3 &#x000d7; 10<sup>9</sup>/L with eosinophil predominance (49.6%) and an absolute eosinophil count of 5.6 &#x000d7; 10<sup>9</sup>/L (Figure&#x000a0;<xref rid="FIG2" ref-type="fig">2</xref>). This prompted a work-up of eosinophilia. His bone marrow aspiration (Figure&#x000a0;<xref rid="FIG3" ref-type="fig">3</xref>) and biopsy were suggestive of normocellular marrow with a prominence of eosinophils and eosinophil precursors (20% eosinophils, 22% myelocytes, and 16% metamyelocytes). His antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibody (ANA) profile were negative (Table&#x000a0;<xref rid="TAB2" ref-type="table">2</xref>). His 2D echocardiogram was also normal. Moreover, during the course of hospitalization, he developed abdominal distension. Abdominal paracentesis was done, which revealed a low serum ascites albumin gradient (SAAG) (1.07), with a cell count of 4.48 &#x000d7; 10<sup>9</sup>/L with 90% eosinophils (4.03 &#x000d7; 10<sup>9</sup>/L, Table&#x000a0;<xref rid="TAB3" ref-type="table">3</xref>, Figure&#x000a0;<xref rid="FIG4" ref-type="fig">4</xref>). Esophageal, gastric, antral, and duodenal biopsies revealed non-specific inflammation with normal eosinophil count. He was given the option of laparoscopic full-thickness biopsy and resection in view of eosinophilic ascites, but he did not consent to the same. In view of the lack of an alternate explanation and as per the diagnostic criteria suggested by Talley et al. (Table&#x000a0;<xref rid="TAB4" ref-type="table">4</xref>), he was started on oral steroids.1 He responded to the treatment and symptomatically improved. His repeat hemogram (fifth day of stating steroid) revealed an absolute eosinophil count of 5.5 &#x000d7; 10<sup>9</sup>/L. He was subsequently discharged and followed up on an outpatient basis. On serial follow-up, the patient was completely free of symptoms and maintained his health even after steroids were gradually tapered and stopped, and his eosinophil count turned out to be normal. He is currently under follow-up for more than a year.</p><table-wrap position="float" id="TAB1"><label>Table 1</label><caption><title>Laboratory investigation of the patient</title><p>AEC - absolute eosinophil count, ALP - alkaline phosphatase, ALT - alanine aminotransferase, AST - aspartate aminotransferase, NAD - nothing abnormal detected, PA - posteroanterior, WBC - white blood cell</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Data</td><td rowspan="1" colspan="1">Day 1</td><td rowspan="1" colspan="1">Day 4</td><td rowspan="1" colspan="1">Day 7</td><td rowspan="1" colspan="1">Day 21</td></tr><tr><td rowspan="1" colspan="1">Hemoglobin (12-15 g/L)</td><td rowspan="1" colspan="1">139</td><td rowspan="1" colspan="1">131</td><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">133</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">WBC count (4-10 &#x000d7; 10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">11.8</td><td rowspan="1" colspan="1">11.3</td><td rowspan="1" colspan="1">13.9</td><td rowspan="1" colspan="1">8.2</td></tr><tr><td rowspan="1" colspan="1">Neutrophils (40-80%)</td><td rowspan="1" colspan="1">49.4</td><td rowspan="1" colspan="1">26.8</td><td rowspan="1" colspan="1">36.7</td><td rowspan="1" colspan="1">49.3</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Lymphocytes (20-40%)</td><td rowspan="1" colspan="1">23.7</td><td rowspan="1" colspan="1">18.4</td><td rowspan="1" colspan="1">18.7</td><td rowspan="1" colspan="1">37</td></tr><tr><td rowspan="1" colspan="1">Monocytes (2-10%)</td><td rowspan="1" colspan="1">5.2</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4.2</td><td rowspan="1" colspan="1">7</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Eosinophils (1-6%)</td><td rowspan="1" colspan="1">20.1</td><td rowspan="1" colspan="1">49.6</td><td rowspan="1" colspan="1">39.9</td><td rowspan="1" colspan="1">5.9</td></tr><tr><td rowspan="1" colspan="1">Basophils (0-1%)</td><td rowspan="1" colspan="1">1.6</td><td rowspan="1" colspan="1">1.2</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">0.8</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Absolute eosinophil count (0.1-0.3 &#x000d7; 10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">2.38</td><td rowspan="1" colspan="1">5.6</td><td rowspan="1" colspan="1">5.5</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Platelet count (150-450 &#x000d7; 10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">265</td><td rowspan="1" colspan="1">261</td><td rowspan="1" colspan="1">412</td><td rowspan="1" colspan="1">250</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Serum bilirubin (1.71-20.52 &#x000b5;mol/L)</td><td rowspan="1" colspan="1">4.78</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">AST (0-40 U/L)</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ALT (0-41 U/L)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">ALP (40-129 U/L)</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Total protein (66-87 g/L)</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Serum albumin (35-52 g/L)</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Serum urea (7.14-35.71 mmol/L)</td><td rowspan="1" colspan="1">12.49</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Serum creatinine (44.21-97.26 &#x000b5;mol/L)</td><td rowspan="1" colspan="1">86.63</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Serum sodium (136-148 mmoL/L)</td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Serum potassium (3.5-5 mmoL/L)</td><td rowspan="1" colspan="1">4.21</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Random blood sugar (3.885-7.77 mmol/L)</td><td rowspan="1" colspan="1">5.11</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Urine routine</td><td rowspan="1" colspan="1">NAD</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Chest X-ray (PA view)</td><td rowspan="1" colspan="1">NAD</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Stool routine</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">-&#x000a0;</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Ultrasound abdomen</td><td rowspan="1" colspan="1">Minimal ascites</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mild to moderate ascites</td><td rowspan="1" colspan="1">-&#x000a0;</td></tr></tbody></table></table-wrap><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>Contrast-enhanced CT scan illustrating duodenal wall thickening (A) and (B) axial contrast-enhanced CT image shows circumferential wall thickening in the duodenum (indicated by the star).</title></caption><graphic xlink:href="cureus-0017-00000076721-i01" position="float"/></fig><fig position="anchor" fig-type="figure" id="FIG2"><label>Figure 2</label><caption><title>Peripheral blood smear showing eosinophilia (Wright-Giemsa stain, 1,000&#x000d7; magnification). Peripheral blood smear revealing marked eosinophilia with abundant bi-lobed eosinophils.</title></caption><graphic xlink:href="cureus-0017-00000076721-i02" position="float"/></fig><fig position="anchor" fig-type="figure" id="FIG3"><label>Figure 3</label><caption><title>Bone marrow aspirate illustrating marked eosinophilic hyperplasia with increased eosinophilic precursors (Wright-Giemsa stain, 1,000&#x000d7; magnification).</title></caption><graphic xlink:href="cureus-0017-00000076721-i03" position="float"/></fig><table-wrap position="float" id="TAB2"><label>Table 2</label><caption><title>Work-up for peripheral eosinophilia to rule out other causes </title><p>ANA - antinuclear antibody, ANCA - antineutrophil cytoplasmic antibodies, ELISA - enzyme-linked immunosorbent assay, HIV - human immunodeficiency virus, IF - immunofluorescence, Ig - immunoglobulin (with class), PBF - peripheral blood film</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Investigations
</td><td rowspan="1" colspan="1">
Result
</td></tr><tr><td rowspan="1" colspan="1">
PBF for immature/dysplastic cells
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Vitamin B12 (160-950 pg/mL)
</td><td rowspan="1" colspan="1">
201
</td></tr><tr><td rowspan="1" colspan="1">
IgE, IgM, IgG
</td><td rowspan="1" colspan="1">
Normal
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
HIV - 1 and 2 (ELISA)
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr><td rowspan="1" colspan="1">
Echocardiography
</td><td rowspan="1" colspan="1">
Normal
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Cardiac enzymes
</td><td rowspan="1" colspan="1">
Normal
</td></tr><tr><td rowspan="1" colspan="1">
Pulmonary function tests
</td><td rowspan="1" colspan="1">
Normal
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Stool multiplex array
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr><td rowspan="1" colspan="1">
Bone marrow aspiration and biopsy
</td><td rowspan="1" colspan="1">
Normal
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
ANA (IF)
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr><td rowspan="1" colspan="1">
ANA profile
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
ANCA profile
</td><td rowspan="1" colspan="1">
Negative
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="TAB3"><label>Table 3</label><caption><title>Ascitic fluid analysis for this patient </title><p>ADA - adenosine deaminase, AFB - acid-fast bacillus</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Parameter
</td><td rowspan="1" colspan="1">
Value
</td></tr><tr><td rowspan="1" colspan="1">
Albumin (3.1-17.7 g/L)
</td><td rowspan="1" colspan="1">
23.4
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Protein (&#x0003c;25 g/L)
</td><td rowspan="1" colspan="1">
38
</td></tr><tr><td rowspan="1" colspan="1">
Glucose (3.885-5.55 mmol/L)
</td><td rowspan="1" colspan="1">
4.77
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Total cells (&#x0003c;0.3 &#x000d7; 10<sup>9</sup>/L)
</td><td rowspan="1" colspan="1">
9.85
</td></tr><tr><td rowspan="1" colspan="1">
Eosinophil count (0.003-0.009 &#x000d7; 10<sup>9</sup>/L)
</td><td rowspan="1" colspan="1">
9.3
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
ADA (&#x0003c;30 U/L)
</td><td rowspan="1" colspan="1">
20
</td></tr><tr><td rowspan="1" colspan="1">
Gram stain
</td><td rowspan="1" colspan="1">
Negative
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Culture
</td><td rowspan="1" colspan="1">
No growth
</td></tr><tr><td rowspan="1" colspan="1">
AFB stain
</td><td rowspan="1" colspan="1">
Absent
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Mycobacterial culture
</td><td rowspan="1" colspan="1">
No growth
</td></tr><tr><td rowspan="1" colspan="1">
Fungal culture
</td><td rowspan="1" colspan="1">
No growth
</td></tr></tbody></table></table-wrap><fig position="anchor" fig-type="figure" id="FIG4"><label>Figure 4</label><caption><title>Ascitic fluid cytology with an eosinophilic predominance (Wright-Giemsa stain, 400&#x000d7; magnification)</title></caption><graphic xlink:href="cureus-0017-00000076721-i04" position="float"/></fig><table-wrap position="float" id="TAB4"><label>Table 4</label><caption><title>Diagnostic criteria for eosinophilic ascites related to eosinophilic gastrointestinal disorders and the presentation in this case meeting the criteria [<xref rid="REF1" ref-type="bibr">1</xref>]</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Feature
</td><td rowspan="1" colspan="1">
Checklist in our case
</td></tr><tr><td rowspan="1" colspan="1">
Gastrointestinal symptoms
</td><td rowspan="1" colspan="1">
Vomiting and pain abdomen ascites
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Tissue diagnosis
</td><td rowspan="1" colspan="1">
Eosinophil-rich ascites
</td></tr><tr><td rowspan="1" colspan="1">
No extraintestinal involvement/alternate explanation
</td><td rowspan="1" colspan="1">
Yes
</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>EGIDs are increasingly recognized worldwide, yet eosinophilic ascites, a rare manifestation of this condition, present a diagnostic challenge due to their non-specific clinical features and overlap with more common causes of ascites [<xref rid="REF7" ref-type="bibr">7</xref>]. Eosinophilic serositis is a rare condition characterized by inflammation of serosal membranes accompanied by an eosinophilic infiltrate. It is a part of the spectrum of EGIDs, with multifactorial pathogenesis, with proposed mechanisms including hypersensitivity reactions, parasitic infections, autoimmune processes, and idiopathic causes [<xref rid="REF8" ref-type="bibr">8</xref>].</p><p>The differential diagnosis of eosinophilic ascites includes infections, malignancies, inflammatory bowel disease, hypereosinophilic syndrome, and vasculitides [<xref rid="REF10" ref-type="bibr">10</xref>]. Diagnosis requires a detailed history to exclude drug-induced eosinophilia, ingestion of raw or uncooked meat, and dietary sources of parasites (Table&#x000a0;<xref rid="TAB5" ref-type="table">5</xref>). A comprehensive personal history, including residence, sanitation, and travel to endemic areas, is vital. Physical examination aids in detecting other causes of eosinophilia and extraintestinal involvement. Furthermore, lymphoproliferative disorders such as Hodgkin lymphoma and certain peripheral T-cell lymphomas derived from CD4 cells, including S&#x000e9;zary syndrome, adult T-cell leukemia/lymphoma, and angioimmunoblastic T-cell lymphoma, also need to be carefully ruled out as these, although rare, can also lead to eosinophilia Laboratory tests, stool studies, ascitic fluid analysis (as in this case), and endoscopy is of utmost importance. While negative mucosal biopsies do not exclude muscular or serosal disease, a laparoscopic full-thickness biopsy or endoscopic mucosal resection (EMR) may help. Diagnosis hinges on eosinophil-rich ascitic fluid and peripheral eosinophilia, necessitating high clinical suspicion [<xref rid="REF11" ref-type="bibr">11</xref>].</p><table-wrap position="float" id="TAB5"><label>Table 5</label><caption><title>Classification of eosinophilic gastrointestinal disorders along with presentation and prevalence as described by Klein et al. [<xref rid="REF5" ref-type="bibr">5</xref>]</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Sub-type
</td><td rowspan="1" colspan="1">
Presentation
</td><td rowspan="1" colspan="1">
Estimated prevalence
</td></tr><tr><td rowspan="1" colspan="1">
Mucosal
</td><td rowspan="1" colspan="1">
Non-specific (depends on area involved) abdominal pain nausea vomiting early satiety diarrhea weight loss malabsorption protein-losing enteropathy failure to thrive
</td><td rowspan="1" colspan="1">
&#x02248;70%
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Muscular
</td><td rowspan="1" colspan="1">
Wall thickening and impaired motility gastric outlet obstruction Intestinal obstruction Pseudoachalasia or esophageal stricture dysphagia regurgitation perforation&#x000a0;
</td><td rowspan="1" colspan="1">
&#x02248;20%
</td></tr><tr><td rowspan="1" colspan="1">
Serosal
</td><td rowspan="1" colspan="1">
Isolated ascites; ascites with above features pleural effusion
</td><td rowspan="1" colspan="1">
&#x02248;10%
</td></tr></tbody></table></table-wrap><p>Eosinophils, typically present in the lamina propria, play an important role in gastrointestinal mucosal immunity. Their numbers increase during inflammatory processes such as parasitic infections and allergic diseases. Activated eosinophils release inflammatory mediators like eosinophil cationic protein and eosinophil-derived neurotoxin, which are cytotoxic to the gastrointestinal epithelium. This triggers mast cell degranulation and release of cytokines (e.g., IL-4, IL-5), chemokines (e.g., eotaxin), and lipid mediators. Th2-type immune responses, particularly elevated cytokines and eotaxin, are critical in eosinophilic gastroenteritis, and with serosal involvement, there is the formation of inflammatory exudative fluid rich in eosinophils [<xref rid="REF11" ref-type="bibr">11</xref>].&#x000a0;</p><p>EGIDs generally respond well to corticosteroids, the primary treatment for inducing remission, with an 80% efficacy rate. Symptoms typically improve within one week, and eosinophil levels normalize within two weeks [<xref rid="REF12" ref-type="bibr">12</xref>]. Alternative treatments, such as antihistamines, montelukast, and sodium cromoglycate, may be useful in cases of relapse, which occurs in about 50% of patients post-steroid discontinuation [<xref rid="REF13" ref-type="bibr">13</xref>]. Immunosuppressive agents like azathioprine or cyclophosphamide may be considered for steroid-resistant cases [<xref rid="REF14" ref-type="bibr">14</xref>]. Dietary interventions, such as six-food or elemental elimination diets over four to six weeks, may induce remission in some patients [<xref rid="REF15" ref-type="bibr">15</xref>]. Emerging therapies include anti-Siglec-8 antibody (Lirentelimab), anti-cytokine (suplatast tosilate), anti-integrin (vedolizumab), and anti-IL5 antibody (benralizumab) [<xref rid="REF16" ref-type="bibr">16</xref>-<xref rid="REF19" ref-type="bibr">19</xref>].</p><p>While EGIDs are being increasingly diagnosed based on a high index of suspicion among gastroenterologists these days, our case was unusual due to the presence of stomach and duodenal mass, which may have contributed to his symptoms. Taking this into consideration, along with the fact that ours is a country with a high incidence of helminth infection, this could very well have been passed under the knife and might have imposed additional morbidity on the patient. The point of discrimination was the worsening of ascites along with the increase in peripheral eosinophilia, which led to further evaluation in this patient, something which could have easily not turned up. This case adds to the limited body of literature on eosinophilic ascites and underscores the need for clinicians to consider this diagnosis in patients with unexplained ascites, particularly when eosinophilia is present.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Early diagnosis of EGIDs is essential to prevent unnecessary surgeries and allow timely management. Recognizing clinical signs like peripheral eosinophilia, ascites, and steroid responsiveness is critical, especially in parasitic-endemic regions. This case highlights key diagnostic indicators and the effectiveness of corticosteroids in managing EGIDs.</p></sec></body><back><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Human subjects:</bold> Consent for treatment and open access publication was obtained or waived by all participants in this study.</p><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Abhinav Gupta</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Abhinav Gupta, Varun Mehta, Manjeet K. Goyal, Manisha Khubber</p><p><bold>Concept and design:</bold>&#x000a0; Varun Mehta, Manjeet K. Goyal, Manisha Khubber, Yogesh K. Gupta</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Varun Mehta, Manjeet K. Goyal, Yogesh K. Gupta</p><p><bold>Supervision:</bold>&#x000a0; Varun Mehta, Manjeet K. Goyal, Yogesh K. Gupta</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues</article-title><source>Gut</source><person-group>
<name><surname>Talley</surname><given-names>NJ</given-names></name>
<name><surname>Shorter</surname><given-names>RG</given-names></name>
<name><surname>Phillips</surname><given-names>SF</given-names></name>
<name><surname>Zinsmeister</surname><given-names>AR</given-names></name>
</person-group><fpage>54</fpage><lpage>58</lpage><volume>31</volume><year>1990</year><pub-id pub-id-type="pmid">2318432</pub-id>
</element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Anti-IgE treatment of eosinophil-associated gastrointestinal disorders</article-title><source>J Allergy Clin Immunol</source><person-group>
<name><surname>Foroughi</surname><given-names>S</given-names></name>
<name><surname>Foster</surname><given-names>B</given-names></name>
<name><surname>Kim</surname><given-names>N</given-names></name>
<etal/>
</person-group><fpage>594</fpage><lpage>601</lpage><volume>120</volume><year>2007</year><pub-id pub-id-type="pmid">17765756</pub-id>
</element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium</article-title><source>Am J Gastroenterol</source><person-group>
<name><surname>Pesek</surname><given-names>RD</given-names></name>
<name><surname>Reed</surname><given-names>CC</given-names></name>
<name><surname>Muir</surname><given-names>AB</given-names></name>
<etal/>
</person-group><fpage>984</fpage><lpage>994</lpage><volume>114</volume><year>2019</year><pub-id pub-id-type="pmid">31008735</pub-id>
</element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature</article-title><source>World J Gastroenterol</source><person-group>
<name><surname>Yun</surname><given-names>MY</given-names></name>
<name><surname>Cho</surname><given-names>YU</given-names></name>
<name><surname>Park</surname><given-names>IS</given-names></name>
<name><surname>Choi</surname><given-names>SK</given-names></name>
<name><surname>Kim</surname><given-names>SJ</given-names></name>
<name><surname>Shin</surname><given-names>SH</given-names></name>
<name><surname>Kim</surname><given-names>KR</given-names></name>
</person-group><fpage>1758</fpage><lpage>1760</lpage><volume>13</volume><year>2007</year><pub-id pub-id-type="pmid">17461485</pub-id>
</element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis</article-title><source>Medicine (Baltimore)</source><person-group>
<name><surname>Klein</surname><given-names>NC</given-names></name>
<name><surname>Hargrove</surname><given-names>RL</given-names></name>
<name><surname>Sleisenger</surname><given-names>MH</given-names></name>
<name><surname>Jeffries</surname><given-names>GH</given-names></name>
</person-group><fpage>299</fpage><lpage>319</lpage><volume>49</volume><year>1970</year><pub-id pub-id-type="pmid">5426746</pub-id>
</element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis - a diagnostic enigma</article-title><source>BMJ Case Rep</source><person-group>
<name><surname>Simoniuk</surname><given-names>U</given-names></name>
<name><surname>McManus</surname><given-names>C</given-names></name>
<name><surname>Kiire</surname><given-names>C</given-names></name>
</person-group><fpage>36</fpage><volume>2012</volume><year>2012</year></element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>A review of eosinophilic gastroenteritis</article-title><source>J Natl Med Assoc</source><person-group>
<name><surname>Baig</surname><given-names>MA</given-names></name>
<name><surname>Qadir</surname><given-names>A</given-names></name>
<name><surname>Rasheed</surname><given-names>J</given-names></name>
</person-group><fpage>1616</fpage><lpage>1619</lpage><volume>98</volume><year>2006</year><uri xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2569760/">https://pmc.ncbi.nlm.nih.gov/articles/PMC2569760/</uri><pub-id pub-id-type="pmid">17052051</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis&#x02014;a complex disease entity</article-title><source>Am J Med</source><person-group>
<name><surname>Cello</surname><given-names>JP</given-names></name>
</person-group><fpage>1097</fpage><lpage>1104</lpage><volume>67</volume><year>1979</year><pub-id pub-id-type="pmid">517550</pub-id>
</element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Eosinophilic esophagitis in a patient with vigorous achalasia</article-title><source>Gastroenterology</source><person-group>
<name><surname>Landres</surname><given-names>RT</given-names></name>
<name><surname>Kuster</surname><given-names>GG</given-names></name>
<name><surname>Strum</surname><given-names>WB</given-names></name>
</person-group><fpage>1298</fpage><lpage>1301</lpage><volume>74</volume><year>1978</year><pub-id pub-id-type="pmid">648822</pub-id>
</element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>Cramping pain and eosinophilic ascites: what is the diagnosis?</article-title><source>Gastroenterology</source><person-group>
<name><surname>Salgueiro</surname><given-names>P</given-names></name>
<name><surname>Magalh&#x000e3;es</surname><given-names>R</given-names></name>
<name><surname>Lago</surname><given-names>P</given-names></name>
</person-group><fpage>1353</fpage><volume>144</volume><year>2013</year><pub-id pub-id-type="pmid">23623877</pub-id>
</element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal"><article-title>A rare cause of ascites</article-title><source>Gastroenterology</source><person-group>
<name><surname>Jarry</surname><given-names>J</given-names></name>
<name><surname>Peycru</surname><given-names>T</given-names></name>
<name><surname>Shekher</surname><given-names>M</given-names></name>
</person-group><fpage>1149</fpage><lpage>1364</lpage><volume>140</volume><year>2011</year><pub-id pub-id-type="pmid">21352871</pub-id>
</element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients</article-title><source>Scand J Gastroenterol</source><person-group>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Duan</surname><given-names>L</given-names></name>
<name><surname>Ding</surname><given-names>S</given-names></name>
<etal/>
</person-group><fpage>1074</fpage><lpage>1080</lpage><volume>46</volume><year>2011</year><pub-id pub-id-type="pmid">21623674</pub-id>
</element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>Eosinophilic enteritis</article-title><source>Dig Dis</source><person-group>
<name><surname>Pineton de Chambrun</surname><given-names>G</given-names></name>
<name><surname>Desreumaux</surname><given-names>P</given-names></name>
<name><surname>Cortot</surname><given-names>A</given-names></name>
</person-group><fpage>183</fpage><lpage>189</lpage><volume>33</volume><year>2015</year><pub-id pub-id-type="pmid">25925921</pub-id>
</element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis: current aspects on etiology, pathogenesis, diagnosis and treatment</article-title><source>Ann Gastroenterol</source><person-group>
<name><surname>Triantafillidis</surname><given-names>J</given-names></name>
<name><surname>Parasi</surname><given-names>A</given-names></name>
<name><surname>Cherakakis</surname><given-names>P</given-names></name>
<name><surname>Sklavaina</surname><given-names>M</given-names></name>
</person-group><fpage>106</fpage><lpage>115</lpage><volume>15</volume><year>2002</year><uri xlink:href="https://www.researchgate.net/profile/John-Triantafillidis/publication/286666991_Eosinophilic_gastroenteritis_Current_aspects_on_etiology_pathogenesis_diagnosis_and_treatment/links/5686423008ae051f9af3e4e6/Eosinophilic-gastroenteritis-Current-aspects-on-etiology-pathogenesis-diagnosis-and-treatment.pdf">https://www.researchgate.net/profile/John-Triantafillidis/publication/286666991_Eosinophilic_gastroenteritis_Current_aspects_on_etiology_pathogenesis_diagnosis_and_treatment/links/5686423008ae051f9af3e4e6/Eosinophilic-gastroenteritis-Current-aspects-on-etiology-pathogenesis-diagnosis-and-treatment.pdf</uri></element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial</article-title><source>J Allergy Clin Immunol</source><person-group>
<name><surname>Gonsalves</surname><given-names>N</given-names></name>
<name><surname>Doerfler</surname><given-names>B</given-names></name>
<name><surname>Zalewski</surname><given-names>A</given-names></name>
<etal/>
</person-group><fpage>676</fpage><lpage>688</lpage><volume>152</volume><year>2023</year><pub-id pub-id-type="pmid">37462600</pub-id>
</element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>Benralizumab for PDGFRA-negative hypereosinophilic syndrome</article-title><source>N Engl J Med</source><person-group>
<name><surname>Kuang</surname><given-names>FL</given-names></name>
<name><surname>Legrand</surname><given-names>F</given-names></name>
<name><surname>Makiya</surname><given-names>M</given-names></name>
<etal/>
</person-group><fpage>1336</fpage><lpage>1346</lpage><volume>380</volume><year>2019</year><pub-id pub-id-type="pmid">30943337</pub-id>
</element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab</article-title><source>Dig Dis Sci</source><person-group>
<name><surname>Grandinetti</surname><given-names>T</given-names></name>
<name><surname>Biedermann</surname><given-names>L</given-names></name>
<name><surname>Bussmann</surname><given-names>C</given-names></name>
<name><surname>Straumann</surname><given-names>A</given-names></name>
<name><surname>Hruz</surname><given-names>P</given-names></name>
</person-group><fpage>2231</fpage><lpage>2241</lpage><volume>64</volume><year>2019</year><pub-id pub-id-type="pmid">30982212</pub-id>
</element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Successful treatment of eosinophilic gastroenteritis with suplatast tosilate</article-title><source>J Allergy Clin Immunol</source><person-group>
<name><surname>Shirai</surname><given-names>T</given-names></name>
<name><surname>Hashimoto</surname><given-names>D</given-names></name>
<name><surname>Suzuki</surname><given-names>K</given-names></name>
<name><surname>Osawa</surname><given-names>S</given-names></name>
<name><surname>Aonahata</surname><given-names>M</given-names></name>
<name><surname>Chida</surname><given-names>K</given-names></name>
<name><surname>Nakamura</surname><given-names>H</given-names></name>
</person-group><fpage>924</fpage><lpage>925</lpage><volume>107</volume><year>2001</year><pub-id pub-id-type="pmid">11344364</pub-id>
</element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal"><article-title>Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis</article-title><source>N Engl J Med</source><person-group>
<name><surname>Dellon</surname><given-names>ES</given-names></name>
<name><surname>Peterson</surname><given-names>KA</given-names></name>
<name><surname>Murray</surname><given-names>JA</given-names></name>
<etal/>
</person-group><fpage>1624</fpage><lpage>1634</lpage><volume>383</volume><year>2020</year><pub-id pub-id-type="pmid">33085861</pub-id>
</element-citation></ref></ref-list></back></article>